Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
5.17
+0.44 (9.30%)
At close: Apr 1, 2026, 4:00 PM EDT
5.23
+0.06 (1.16%)
After-hours: Apr 1, 2026, 7:46 PM EDT
Atara Biotherapeutics Market Cap
Atara Biotherapeutics has a market cap or net worth of $42.28 million as of April 1, 2026. Its market cap has increased by 2.87% in one year.
Market Cap
42.28M
Enterprise Value
44.17M
1-Year Change
2.87%
Ranking
Category
Stock Price
$5.17
Market Cap Chart
Since October 16, 2014, Atara Biotherapeutics's market cap has decreased from $215.30M to $42.28M, a decrease of -80.36%. That is a compound annual growth rate of -13.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 42.30M | -67.56% |
| Dec 31, 2025 | 130.40M | 70.01% |
| Dec 31, 2024 | 76.70M | 46.65% |
| Dec 29, 2023 | 52.30M | -83.19% |
| Dec 30, 2022 | 311.20M | -77.67% |
| Dec 31, 2021 | 1.39B | -8.65% |
| Dec 31, 2020 | 1.53B | 71.04% |
| Dec 31, 2019 | 891.90M | -43.76% |
| Dec 31, 2018 | 1.59B | 186.35% |
| Dec 29, 2017 | 553.80M | 35.14% |
| Dec 30, 2016 | 409.80M | -45.80% |
| Dec 31, 2015 | 756.10M | 39.84% |
| Dec 31, 2014 | 540.70M | 151.14% |
| Oct 16, 2014 | 215.30M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Edesa Biotech | 43.66M |
| Lite Strategy | 42.18M |
| Werewolf Therapeutics | 40.46M |
| Sensei Biotherapeutics | 39.89M |
| NovaBay Pharmaceuticals | 39.67M |
| Celularity | 38.35M |
| NextCure | 38.03M |
| Palatin Technologies | 36.77M |